COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
05 2021
Historique:
revised: 28 12 2020
received: 29 10 2020
accepted: 02 01 2021
pubmed: 7 1 2021
medline: 22 4 2021
entrez: 6 1 2021
Statut: ppublish

Résumé

With the COVID-19 pandemic, chemosensory dysfunction are among the most prevalent symptoms. Most reports are subjective evaluations, which have been suggested to be unreliable. The objective is to test chemosensory dysfunction and recovery based on extensive psychophysical tests in COVID-19 during the course of the disease. Prospective cohort study. A total of 111 patients from four centers participated in the study. All tested positive for SARS-COV-2 with RT-PCR. They were tested within 3 days of diagnosis and 28 to 169 days after infection. Testing included extensive olfactory testing with the Sniffin' Sticks test for threshold, discrimination and identification abilities, and with the Taste Sprays and Taste Strips for gustatory function for quasi-threshold and taste identification abilities. There was a significant difference in olfactory function during and after infection. During infection 21% were anosmic, 49% hyposmic, and 30% normosmic. After infection only 1% were anosmic, 26% hyposmic, and 73% normosmic. For gustatory function, there was a difference for all taste qualities, but significantly in sour, bitter, and total score. Twenty-six percent had gustatory dysfunction during infection and 6.5% had gustatory dysfunction after infection. Combining all tests 22% had combined olfactory and gustatory dysfunction during infection. After infection no patients had combined dysfunction. Chemosensory dysfunction is very common in COVID-19, either as isolated smell or taste dysfunction or a combined dysfunction. Most people regain their chemosensory function within the first 28 days, but a quarter of the patients show persisting dysfunction, which should be referred to specialist smell and taste clinics for rehabilitation of chemosensory function. 3 Laryngoscope, 131:1095-1100, 2021.

Identifiants

pubmed: 33404079
doi: 10.1002/lary.29383
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1095-1100

Informations de copyright

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Références

Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the Skövde population-based study. Laryngoscope 2004;114:733-737.
Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope 2004;114:1764-1769.
Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurol 2008;255:1121-1126.
Fjaeldstad A, Stankovic J, Onat M, Stankevice D, Ovesen T. Patients and experiences from the first Danish flavour clinic. Dan Med J 2020;67:5.
Temmel AFP, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002;128:635-641.
Welge-Lüssen A, Dörig P, Wolfensberger M, Krone F, Hummel T. A study about the frequency of taste disorders. J Neurol 2011;258:386-392.
Hannum ME, Ramirez VA, Lipson SJ, et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 positive patients compared to subjective methods: a systematic review and meta-analysis. medRxiv. 2020:2020.07.04.20145870.
Bocksberger S, Wagner W, Hummel T, et al. Temporary hyposmia in COVID-19 patients. HNO 2020;68:440-443.
Huart C, Philpott C, Konstantinidis I, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology 2020;58:623-625.
Klimek L, Hagemann J, Alali A, et al. Telemedicine allows quantitative measuring of olfactory dysfunction in COVID-19. Allergy 2020.
Mullol J, Alobid I, Mariño-Sánchez F, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep 2020;20:61.
Vaira LA, Salzano G, Petrocelli M, Deiana G, Salzano FA, De Riu G. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck 2020;42:1570-1576.
Vaira LA, Hopkins C, Salzano G, et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 2020;42:1560-1569.
Hornuss D, Lange B, Schröter N, Rieg S, Kern WV, Wagner D. Anosmia in COVID-19 patients. Clin Microbiol Infect 2020;26:1426-1427.
Landis BN, Hummel T, Hugentobler M, Giger R, Lacroix JS. Ratings of overall olfactory function. Chem Senses 2003;28:691-694.
Lötsch J, Hummel T. Clinical usefulness of self-rated olfactory performance-a data science-based assessment of 6000 patients. Chem Senses 2019;44:357-364.
Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the "Sniffin' sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007;264:237-243.
Landis B, Welge-Luessen A, Brämerson A, et al. “Taste strips” - a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 2009;256:242-248.
Hummel T, Hummel C, Welge-Luessen A. Assessment of olfaction and gustation. In: Welge-Luessen A, Hummel T, eds. Management of Smell and Taste Disorders: A Practical Guide for Clinicians. Stuttgart, Germany: Thieme; 2013:58-75.
Doty RL, Chen JH, Overend J. Taste quality confusions: influences of age, smoking, PTC taster status, and other subject characteristics. Perception 2017;46:257-267.
Pilková L, Nováková M, Pokorný J. Naming and identification of tastes in aqueous solutions. Nahrung 1991;35:999-1002.
Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22:39-52.
Oleszkiewicz A, Schriever VA, Croy I, Hahner A, Hummel T. Updated Sniffin' sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol 2019;276:719-728.
Niklassen AS, Ovesen T, Fernandes H, Fjaeldstad AW. Danish validation of sniffin' sticks olfactory test for threshold, discrimination, and identification. Laryngoscope 2017;114:1764.
Hummel T, Konnerth CG, Rosenheim K, Kobal G. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001;110:976-981.
Worldometers.info. Dover, Delaware, U.S.A.
Vaira LA, Hopkins C, Petrocelli M, et al. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol 2020;134:703-709.
Landis BN, Scheibe M, Weber C, et al. Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol 2010;257:1303-1308.
Migneault-Bouchard C, Hsieh JW, Hugentobler M, Frasnelli J, Landis BN. Chemosensory decrease in different forms of olfactory dysfunction. J Neurol 2020;267:138-143.
Gudziol H, Rahneberg K, Burkert S. Anosmics are more poorly able to taste than normal persons. Laryngorhinootologie 2007;86:640-643.
Petrocelli M, Ruggiero F, Baietti AM, et al. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol 2020;134:571-576.
Altin F, Cingi C, Uzun T, Bal C. Olfactory and gustatory abnormalities in COVID-19 cases. Eur Arch Otorhinolaryngol 2020;277:2775-2781.
Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA 2020;323:2512-2514.

Auteurs

Andreas Steenholt Niklassen (AS)

Smell and Taste Clinic, Department of Otorhinolaryngology, Technical University Dresden, Dresden, Germany.
Flavour Institute, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Ear, nose, and throat Department, Regional Hospital West, Holstebro, Denmark.

Julia Draf (J)

Smell and Taste Clinic, Department of Otorhinolaryngology, Technical University Dresden, Dresden, Germany.

Caroline Huart (C)

Department of Otorhinolaryngology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Institute of Neuroscience, Université catholique de Louvain, Brussels, Belgium.

Constantin Hintschich (C)

Department of Otorhinolaryngology, Regensburg University Hospital, Regensburg, Germany.

Simone Bocksberger (S)

Department of Otolaryngology, Head and Neck Surgery, Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians University, Munich, Germany.

Eleonora Maria Consiglia Trecca (EMC)

Department of Otolaryngology, University of Foggia, Foggia, Italy.

Ludger Klimek (L)

Center of Rhinology and Allergology, Wiesbaden, Germany.

Serge D Le Bon (SD)

Department of Otorhinolaryngology and Head and Neck Surgery, CHU de Bruxelles, CHU Saint-Pierre, School of Medicine, Université Libre de Bruxelles, Brussels, Belgium.

Aytug Altundag (A)

Department of Otorhinolaryngology, Biruni University, Istanbul, Turkey.

Thomas Hummel (T)

Smell and Taste Clinic, Department of Otorhinolaryngology, Technical University Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH